Estuary Biotherapeutics
Menlo Park, California, United States · Biotechnology, Genetics, Health Care
Estuary Biotherapeutics, Inc. is a biotechnology company focused on developing genetic medicines for patients with serious kidney diseases. The company aims to create targeted gene therapies that address the underlying causes of these conditions. Its innovative approach may significantly improve treatment options for affected patients.
Key facts
- Headquarters
- Menlo Park, California, United States
- Employees
- 11
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Private
- Website
- estuarybio.com
- Company page
Recent activity at Estuary Biotherapeutics
Estuary Biotherapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Series A | $93.0M |
Employee benefit plans
Estuary Biotherapeutics files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Estuary Biotherapeutics in the news
Companies similar to Estuary Biotherapeutics
- Aurora Therapeutics · Biotechnology, Genetics, Health Care, Therapeutics
- Junevity · Biotechnology, Genetics, Health Care, Therapeutics
- Aptadir Therapeutics · Biotechnology, Genetics, Health Care, Therapeutics
- Exegenesis Bio · Biotechnology, Genetics, Health Care, Therapeutics
- miRecule · Biotechnology, Genetics, Health Care, Therapeutics
About Estuary Biotherapeutics: questions and answers
What does Estuary Biotherapeutics do?
Estuary Biotherapeutics, Inc. is a biotechnology company focused on developing genetic medicines for patients with serious kidney diseases. The company aims to create targeted gene therapies that address the underlying causes of these conditions. Its innovative approach may significantly improve treatment options for affected patients.
Where is Estuary Biotherapeutics headquartered?
Estuary Biotherapeutics is headquartered in Menlo Park, California, United States.
How many employees does Estuary Biotherapeutics have?
Estuary Biotherapeutics has about 11 employees.
Has Estuary Biotherapeutics raised funding?
Yes. Fundz has recorded 1 funding event for Estuary Biotherapeutics. The most recent, Series A of $93.0M, was in Oct 2026.
What is the latest news on Estuary Biotherapeutics?
On Oct 16, 2026, Estuary Biotherapeutics raises $93 million in Series A financing, led by RA Capital Management, to develop targeted gene therapies for kidney disease.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy